CYTOMX THERAPEUTICS INC's ticker is CTMX and the CUSIP is 23284F105. A total of 128 filers reported holding CYTOMX THERAPEUTICS INC in Q1 2021. The put-call ratio across all filers is 2.74 and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2021 | $30,000 | -18.9% | 5,922 | 0.0% | 0.00% | – |
Q2 2021 | $37,000 | -19.6% | 5,922 | 0.0% | 0.00% | – |
Q1 2021 | $46,000 | +17.9% | 5,922 | 0.0% | 0.00% | – |
Q4 2020 | $39,000 | 0.0% | 5,922 | 0.0% | 0.00% | – |
Q3 2020 | $39,000 | -20.4% | 5,922 | 0.0% | 0.00% | – |
Q2 2020 | $49,000 | +157.9% | 5,922 | +141.4% | 0.00% | – |
Q1 2020 | $19,000 | -5.0% | 2,453 | 0.0% | 0.00% | – |
Q4 2019 | $20,000 | +11.1% | 2,453 | 0.0% | 0.00% | – |
Q3 2019 | $18,000 | -35.7% | 2,453 | 0.0% | 0.00% | – |
Q2 2019 | $28,000 | +7.7% | 2,453 | 0.0% | 0.00% | – |
Q1 2019 | $26,000 | -29.7% | 2,453 | 0.0% | 0.00% | – |
Q4 2018 | $37,000 | -17.8% | 2,453 | 0.0% | 0.00% | – |
Q3 2018 | $45,000 | -19.6% | 2,453 | 0.0% | 0.00% | – |
Q2 2018 | $56,000 | -40.4% | 2,453 | -25.5% | 0.00% | -100.0% |
Q1 2018 | $94,000 | +36.2% | 3,291 | 0.0% | 0.00% | 0.0% |
Q4 2017 | $69,000 | – | 3,291 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
BVF INC/IL | 5,803,700 | $25,130,000 | 0.91% |
Altium Capital Management LP | 663,800 | $2,874,000 | 0.79% |
Rubric Capital Management LP | 2,406,449 | $10,420,000 | 0.49% |
RTW INVESTMENTS, LP | 6,029,700 | $26,109,000 | 0.38% |
Orbimed Advisors | 3,214,509 | $13,919,000 | 0.18% |
TANG CAPITAL MANAGEMENT LLC | 152,345 | $660,000 | 0.13% |
PLATINUM INVESTMENT MANAGEMENT LTD | 980,085 | $4,244,000 | 0.12% |
Point72 Asset Management, L.P. | 6,303,025 | $27,292,000 | 0.11% |
Sender Co & Partners, Inc. | 40,720 | $176,000 | 0.09% |
Manteio Capital LLC | 15,067 | $65,000 | 0.08% |